Main Article Content
Primary cutaneous CD30 anaplastic large cell lymphoma, PCALCL, lymphomatoid papulosis, LyP, anaplastic lymphoma kinase, ALK, reactive lymphoid hyperplasia
Abstract not available.
2. Vergier B, Beylot-Barry M, Pulford K, et al. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol. 1998;22(10):1192-1202.
3. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95(12):3653-3661.
4. Liu HL, Hoppe RT, Kohler S, et al. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49(6):1049-58.
5. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-85.
6. Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011:118(15):4024-4035.
7. Shehan, JM, Kalaaji AN, Markovic SN, et al. Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma. J Am Acad Dermatol. 2004;51(1):103-110.
8. Moodley N, Nombona P, Mosam A. Primary Cutaneous Anaplastic Large-Cell Lymphoma. Dermatopathology, 2019;6(2):163-169.
9. Kang, S. K., Chang, S. E., Choi, J. H., Sung, K. J., Moon, K. C., & Koh, J. K. (2002). Coexistence of CD30‐positive anaplastic large cell lymphoma and mycosis fungoides. Clinical and experimental dermatology, 27(3), 212-215.
10. Werner Kempf, M. D., Katrin Kerl, M. D., & Christina Mitteldorf, M. D. (2018, March). Cutaneous CD30-positive T-cell lymphoproliferative disorders—clinical and histopathologic features, differential diagnosis, and treatment. In Seminars in cutaneous medicine and surgery (Vol. 37, pp. 24-29).